Clinical Trial Update: A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study by Incyte evaluating INCB013739 and its effect on cortisone-reducing enzyme activity in obese individuals p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity

Drugs mentioned

• INCB013739

Snippet

Sponsor: Incyte Corporation | Conditions: Insulin Resistance, Obesity | Phase 1 | Status: COMPLETED